For instance, the SAA1 lung cancer biomarker, neuro-inflammation factor MMP1, the chemokine ligands (C-C motifs) CCL2, CCL5, and CCL20, and cytokines such as IL6, IL8, IL16, were all significantly modulated. This evidence concerns the gene CCL2 and lung carcinoma.